IndiaMart
FIEO
Dermorphin 5mg is a naturally occurring opioid peptide originally isolated from the skin secretions of South American tree frogs. It exhibits high potency and selectivity for the mu-opioid receptor, making it a valuable compound for pain management, analgesic, and neuropharmacological research.
Composed of seven amino acids, Dermorphin 5mg demonstrates significantly higher activity than morphine in experimental settings, while maintaining a distinct peptide-based structure. Researchers utilize this compound to explore neuromodulation, receptor binding, and pain-relief mechanisms in both pharmaceutical and academic studies.
BLUEPILL EXPRESS, a global merchant exporter, offers Dermorphin 5mg manufactured in GMP-certified facilities based in India and China, depending on client needs and export regulations. Every batch undergoes HPLC and mass spectrometry verification to confirm purity, potency, and consistency, ensuring reliable research-grade quality.
Key Features of Dermorphin 5mg:
- High-purity opioid peptide for advanced neurological research
- Selective mu-opioid receptor agonist used in pain and receptor studies
- Exhibits greater potency than morphine in controlled research environments
- Ideal for analgesic, behavioral, and neurochemical investigations
- Manufactured in India and China under GMP certification
- Supplied globally by BLUEPILL EXPRESS – Merchant Exporter
- Accompanied by COA, MSDS, and full export documentation
- Available in bulk, OEM, and private-label formats
- Ensures stable formulation and global logistics support
As a merchant exporter, BLUEPILL EXPRESS specializes in supplying research peptides, bioactive compounds, and pharmaceutical intermediates worldwide. Our catalog includes Dermorphin 5mg, BPC157, TB500, CJC-1295, GHK-Cu, Semaglutide, and more—produced under strict GMP guidelines in India and China.
With BLUEPILL EXPRESS, clients gain access to competitive pricing, consistent quality assurance, and customized export solutions—making us a reliable global partner for research institutions, biotech organizations, and pharmaceutical developers.
